Patent 7427636 was granted and assigned to Gilead Sciences on September, 2008 by the United States Patent and Trademark Office.
The invention is related to phosphorus substituted IMPDH inhibitory compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.